Humana Inc. kicked off the trading day on 10/10/19 with a price increase of 2.90%, equivalent to $7.35 relative change for the day. Taking a more long-term approach, HUM had a 52-week range of $225.65 to $355.88. At the time of this article’s publishing, this stock is trading at $261.15 after starting the trading session at $257.41. At the time of writing, this stock’s 50-day Moving Average stands at $278.10, while the 200-day Moving Average of this stock is currently $273.39.
Currently, this company’s share volume is sitting at $1198065, but has maintained average daily volume of $1.06M. This stock has generated an average Year to Date volume of $1.25 million, alongside an average 20-day volume of $1.04 million. This publicly-traded company’s shares outstanding now amounts to $135.06 million, simultaneously with a float of $134.82 million. The organization now has a market capitalization sitting at $35.27 billion.
Humana Inc.(HUM) Ownership Data
Now let’s turn our focus to how large-scale investors are behaving with this stock. Humana Inc.’s current insider ownership accounts for 0.20%, in contrast to 95.30% institutional ownership. According to the most recent latest insider trade that took place on Sep 01 this organization’s Chief Dig Health & Analyt Off. exercised an option 751 at the rate of 0.00, making the entire transaction hit 0 in total value, affecting insider ownership by 751. Preceding that transaction, on Aug 22 Company’s Strategic Advisor exercised an option 7,239 at a price of 232.04, making the whole transaction’s value amount to 1,679,704. This particular insider is now the holder of 15,067 in total.
If we take a glance at the Ownership summary of Humana Inc.’s stock, Institutional holders make up 95.30% of its total stock ownership. All together, they are the legal holders of 135.06M shares. If we focus on the top 3 stockholders for this publicly-traded organization, Capital Research & Management Co. (International Investors) owns 10,032,148 shares, with The Vanguard Group, Inc. in 2nd place owning 10,031,921 shares and Capital Research & Management Co. (Global Investors) in third place with total ownership of 6,972,920 shares.
Humana Inc. (HUM) Earnings and Revenue Data
In the latest quarterly report that this company released, which was put into the public domain on 6/29/2019, the organization reported $6.05 earnings per share (EPS) for the three-month period, surpassing the consensus estimate (set at $5.3) by $0.75.
This company achieved a net margin of 4.13 while generating a return on equity of 23.33. Wall Street market experts anticipate that the next fiscal year will bring earnings of 2.52 per share during the current fiscal year.
Humana Inc.’s EPS decrease for this current 12-month fiscal period is -29.80%, and is forecasted to reach 18.73 in the upcoming year. Looking at the long run, market analysts have predicted that Company’s EPS will increase by 13.19% through the next 5 years, which can be compared against the 10.00% growth it accomplished over the previous five years trading on the market.
Additional Trading Performance Indicators
The company has managed to achieve an average true range (ATR) of 6.54. Alongside those, its PE Ratio stands at $14.11, and its Beta score is 0.81.
Another valuable indicator worth considering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.58 for this organization. Similarly, its price to free cash flow for trailing twelve months is now 1410.87. Plus, this company’s price to book ratio for the last three-month fiscal period reported is 2.97, whereas its price to cash per share for the last quarter landed at 35.38.
In the same vein, HUM’s Diluted EPS (Earnings per Share) trailing twelve months was posted at 18.51, a figure that is expected to reach 4.58 in the next reported quarter, and analysts expect it will be 18.73 at the market close of one year from today’s date.